Cite
MLA Citation
Michael Schiff et al.. “Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial.” Annals of the rheumatic diseases, vol. 73, no. 1, 2014, pp. 86–94. http://access.bl.uk/ark:/81055/vdc_100137784729.0x000060